| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinitis Pigmentosa | 77 | 2010 | 397 | 8.020 |
Why?
|
| Eye Proteins | 37 | 2008 | 633 | 3.960 |
Why?
|
| Retinoblastoma | 41 | 2020 | 317 | 2.830 |
Why?
|
| Rhodopsin | 30 | 2009 | 203 | 2.500 |
Why?
|
| Retinal Degeneration | 17 | 2019 | 413 | 1.950 |
Why?
|
| Genes, Recessive | 27 | 2008 | 623 | 1.820 |
Why?
|
| Macular Degeneration | 13 | 2023 | 1007 | 1.710 |
Why?
|
| Night Blindness | 13 | 2008 | 56 | 1.610 |
Why?
|
| Mutation, Missense | 18 | 2010 | 2571 | 1.540 |
Why?
|
| Genes, Dominant | 23 | 2009 | 852 | 1.520 |
Why?
|
| Uveal Neoplasms | 6 | 2021 | 341 | 1.430 |
Why?
|
| Photoreceptor Cells, Vertebrate | 11 | 2009 | 203 | 1.410 |
Why?
|
| Pedigree | 71 | 2008 | 4542 | 1.380 |
Why?
|
| Electroretinography | 39 | 2009 | 525 | 1.360 |
Why?
|
| Point Mutation | 22 | 2005 | 1595 | 1.320 |
Why?
|
| Eye Neoplasms | 27 | 2007 | 307 | 1.180 |
Why?
|
| Choroidal Neovascularization | 6 | 2016 | 363 | 1.150 |
Why?
|
| Retinal Neoplasms | 6 | 2020 | 146 | 1.080 |
Why?
|
| Mutation | 65 | 2010 | 30052 | 1.080 |
Why?
|
| Retinal Rod Photoreceptor Cells | 10 | 2008 | 204 | 0.940 |
Why?
|
| Genes, Retinoblastoma | 12 | 2001 | 125 | 0.920 |
Why?
|
| DNA Mutational Analysis | 29 | 2006 | 4111 | 0.890 |
Why?
|
| Chromosomes, Human, Pair 13 | 12 | 1999 | 192 | 0.880 |
Why?
|
| Retinal Diseases | 10 | 2017 | 705 | 0.870 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 7 | 1999 | 56 | 0.870 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 4 | 2007 | 50 | 0.860 |
Why?
|
| Blindness | 9 | 2008 | 584 | 0.850 |
Why?
|
| Eye Diseases, Hereditary | 4 | 2005 | 122 | 0.830 |
Why?
|
| Ciliary Body | 4 | 2021 | 167 | 0.790 |
Why?
|
| Retina | 18 | 2023 | 2659 | 0.760 |
Why?
|
| Frameshift Mutation | 5 | 2007 | 392 | 0.730 |
Why?
|
| Extracellular Matrix Proteins | 6 | 2010 | 829 | 0.710 |
Why?
|
| Complement System Proteins | 2 | 2021 | 736 | 0.690 |
Why?
|
| Molecular Biology | 3 | 2020 | 576 | 0.680 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2019 | 55 | 0.680 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 17 | 2003 | 329 | 0.680 |
Why?
|
| Retinal Cone Photoreceptor Cells | 6 | 2008 | 184 | 0.670 |
Why?
|
| Molecular Sequence Data | 56 | 2006 | 17635 | 0.670 |
Why?
|
| Base Sequence | 48 | 2017 | 12441 | 0.670 |
Why?
|
| Pigment Epithelium of Eye | 10 | 2021 | 209 | 0.640 |
Why?
|
| Eye Infections | 1 | 2019 | 62 | 0.640 |
Why?
|
| Alleles | 26 | 2017 | 6863 | 0.630 |
Why?
|
| Cytogenetics | 1 | 2019 | 198 | 0.630 |
Why?
|
| Cytogenetic Analysis | 1 | 2019 | 270 | 0.620 |
Why?
|
| Genetic Linkage | 14 | 2001 | 2341 | 0.600 |
Why?
|
| Heterozygote | 16 | 2017 | 2787 | 0.600 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2023 | 303 | 0.570 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2017 | 277 | 0.560 |
Why?
|
| Orbital Neoplasms | 1 | 2019 | 222 | 0.560 |
Why?
|
| Visual Acuity | 22 | 2008 | 2672 | 0.550 |
Why?
|
| Polymorphism, Restriction Fragment Length | 16 | 1993 | 767 | 0.530 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 358 | 0.530 |
Why?
|
| Sequence Analysis, DNA | 12 | 2019 | 4740 | 0.530 |
Why?
|
| Fundus Oculi | 13 | 2014 | 556 | 0.500 |
Why?
|
| Haplotypes | 3 | 2017 | 2713 | 0.500 |
Why?
|
| Optic Atrophies, Hereditary | 3 | 2001 | 27 | 0.490 |
Why?
|
| Photoreceptor Cells | 9 | 1998 | 236 | 0.490 |
Why?
|
| Chromosomes, Human, 13-15 | 12 | 1988 | 49 | 0.480 |
Why?
|
| Transducin | 7 | 2005 | 42 | 0.480 |
Why?
|
| Amino Acid Sequence | 36 | 2005 | 13446 | 0.480 |
Why?
|
| Codon, Nonsense | 2 | 2006 | 285 | 0.460 |
Why?
|
| Rod Cell Outer Segment | 5 | 1997 | 51 | 0.450 |
Why?
|
| Alcohol Oxidoreductases | 3 | 2008 | 169 | 0.440 |
Why?
|
| Dark Adaptation | 15 | 2008 | 222 | 0.440 |
Why?
|
| Retinaldehyde | 4 | 2004 | 24 | 0.430 |
Why?
|
| Deafness | 4 | 2001 | 459 | 0.420 |
Why?
|
| Proline | 6 | 2000 | 457 | 0.420 |
Why?
|
| DNA Primers | 15 | 2008 | 2819 | 0.420 |
Why?
|
| Polymerase Chain Reaction | 22 | 2019 | 6075 | 0.400 |
Why?
|
| Laser Coagulation | 1 | 2014 | 330 | 0.400 |
Why?
|
| DNA | 25 | 2002 | 7212 | 0.400 |
Why?
|
| Interleukin-17 | 2 | 2015 | 912 | 0.390 |
Why?
|
| Visual Fields | 17 | 2018 | 1062 | 0.390 |
Why?
|
| Protein Kinases | 4 | 2004 | 1608 | 0.390 |
Why?
|
| Rod Opsins | 7 | 1999 | 108 | 0.390 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3617 | 0.390 |
Why?
|
| Chromosome Mapping | 24 | 2007 | 4615 | 0.390 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2020 | 0.370 |
Why?
|
| Polymorphism, Genetic | 20 | 2006 | 4243 | 0.370 |
Why?
|
| Retinal Pigments | 4 | 2008 | 83 | 0.370 |
Why?
|
| Dry Eye Syndromes | 1 | 2015 | 387 | 0.370 |
Why?
|
| Intermediate Filament Proteins | 4 | 1997 | 262 | 0.370 |
Why?
|
| Membrane Proteins | 9 | 2017 | 7856 | 0.370 |
Why?
|
| Physician Executives | 1 | 2012 | 134 | 0.360 |
Why?
|
| Uterine Neoplasms | 1 | 2019 | 1420 | 0.360 |
Why?
|
| Eyelid Neoplasms | 3 | 2018 | 89 | 0.360 |
Why?
|
| Exons | 17 | 2008 | 2391 | 0.360 |
Why?
|
| Rare Diseases | 2 | 2005 | 622 | 0.350 |
Why?
|
| Carrier Proteins | 6 | 2004 | 4936 | 0.350 |
Why?
|
| Homozygote | 8 | 2017 | 1776 | 0.340 |
Why?
|
| Eye Diseases | 5 | 2006 | 653 | 0.340 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2002 | 155 | 0.340 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 999 | 0.340 |
Why?
|
| Genetic Counseling | 4 | 2020 | 627 | 0.340 |
Why?
|
| Chromosome Deletion | 12 | 1996 | 1386 | 0.330 |
Why?
|
| Genetic Heterogeneity | 4 | 2004 | 732 | 0.330 |
Why?
|
| Humans | 208 | 2023 | 761504 | 0.330 |
Why?
|
| IMP Dehydrogenase | 2 | 2005 | 33 | 0.310 |
Why?
|
| Adenocarcinoma | 7 | 2021 | 6346 | 0.310 |
Why?
|
| Female | 121 | 2023 | 392644 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 1999 | 350 | 0.290 |
Why?
|
| Codon | 10 | 1999 | 601 | 0.280 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2006 | 33 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2002 | 638 | 0.280 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 141 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3639 | 0.270 |
Why?
|
| Male | 108 | 2023 | 360804 | 0.270 |
Why?
|
| X Chromosome | 4 | 2000 | 816 | 0.270 |
Why?
|
| Ion Channels | 2 | 2005 | 1040 | 0.260 |
Why?
|
| Uniparental Disomy | 2 | 2002 | 45 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 3164 | 0.250 |
Why?
|
| Ophthalmology | 1 | 2012 | 550 | 0.250 |
Why?
|
| Acyltransferases | 1 | 2007 | 305 | 0.250 |
Why?
|
| Color Vision Defects | 1 | 2005 | 28 | 0.240 |
Why?
|
| Arrestin | 4 | 1998 | 30 | 0.240 |
Why?
|
| Introns | 7 | 2006 | 981 | 0.240 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2005 | 105 | 0.240 |
Why?
|
| Uveal Diseases | 3 | 2002 | 45 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 6 | 2002 | 4414 | 0.240 |
Why?
|
| Proteins | 4 | 2017 | 6032 | 0.230 |
Why?
|
| Syndrome | 7 | 2005 | 3267 | 0.230 |
Why?
|
| Corneal Dystrophies, Hereditary | 2 | 2005 | 64 | 0.230 |
Why?
|
| Melanoma | 6 | 2020 | 5709 | 0.230 |
Why?
|
| Vision, Ocular | 3 | 2008 | 455 | 0.230 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 4249 | 0.230 |
Why?
|
| Homeodomain Proteins | 3 | 2002 | 2416 | 0.230 |
Why?
|
| RGS Proteins | 1 | 2004 | 74 | 0.220 |
Why?
|
| Trans-Activators | 3 | 2002 | 2856 | 0.220 |
Why?
|
| Melanocytes | 4 | 2002 | 509 | 0.220 |
Why?
|
| Phosphoproteins | 4 | 2004 | 2448 | 0.220 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2005 | 195 | 0.220 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2004 | 75 | 0.220 |
Why?
|
| Oncogenes | 7 | 1990 | 1222 | 0.210 |
Why?
|
| Telomere | 1 | 2009 | 943 | 0.210 |
Why?
|
| Optic Disk Drusen | 1 | 2023 | 38 | 0.210 |
Why?
|
| Gene Frequency | 5 | 2008 | 3606 | 0.210 |
Why?
|
| Carboxylesterase | 5 | 1986 | 31 | 0.200 |
Why?
|
| Leadership | 1 | 2012 | 1385 | 0.200 |
Why?
|
| Adult | 64 | 2021 | 221177 | 0.200 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2002 | 89 | 0.200 |
Why?
|
| Endometrial Neoplasms | 2 | 2002 | 1366 | 0.200 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2019 | 738 | 0.200 |
Why?
|
| Complement Pathway, Alternative | 2 | 2021 | 113 | 0.190 |
Why?
|
| Adaptation, Ocular | 2 | 1999 | 89 | 0.190 |
Why?
|
| Keratoconus | 1 | 2023 | 112 | 0.190 |
Why?
|
| Apolipoproteins E | 1 | 2007 | 1444 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 9177 | 0.180 |
Why?
|
| Cloning, Molecular | 14 | 2019 | 4174 | 0.180 |
Why?
|
| Macula Lutea | 1 | 2001 | 177 | 0.180 |
Why?
|
| Vision Disorders | 2 | 2007 | 1088 | 0.180 |
Why?
|
| Gelsolin | 1 | 2001 | 189 | 0.180 |
Why?
|
| Choroid | 3 | 2021 | 360 | 0.170 |
Why?
|
| Genetic Testing | 6 | 2020 | 3537 | 0.170 |
Why?
|
| Vitreous Body | 3 | 1999 | 399 | 0.170 |
Why?
|
| Isoenzymes | 3 | 1999 | 1687 | 0.170 |
Why?
|
| Retinol-Binding Proteins | 2 | 2008 | 67 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11903 | 0.170 |
Why?
|
| Penetrance | 2 | 1999 | 383 | 0.170 |
Why?
|
| Middle Aged | 52 | 2021 | 220895 | 0.160 |
Why?
|
| Germ-Line Mutation | 2 | 1998 | 1858 | 0.160 |
Why?
|
| Complement Activation | 1 | 2021 | 445 | 0.160 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.160 |
Why?
|
| Gene Expression | 8 | 2006 | 7581 | 0.160 |
Why?
|
| Complement Factor H | 3 | 2008 | 110 | 0.160 |
Why?
|
| Corneal Transplantation | 1 | 2023 | 321 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 857 | 0.160 |
Why?
|
| Calcium Channel Blockers | 2 | 2019 | 694 | 0.160 |
Why?
|
| Myosins | 1 | 2000 | 405 | 0.160 |
Why?
|
| Hidrocystoma | 1 | 2018 | 11 | 0.160 |
Why?
|
| Carboxylic Ester Hydrolases | 5 | 1986 | 99 | 0.160 |
Why?
|
| Ophthalmoplegia | 1 | 2019 | 168 | 0.150 |
Why?
|
| Amino Acid Substitution | 4 | 2007 | 1738 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 9606 | 0.150 |
Why?
|
| Complement Factor D | 1 | 2018 | 66 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 17904 | 0.150 |
Why?
|
| Diagnosis, Differential | 7 | 2020 | 12974 | 0.150 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2001 | 563 | 0.150 |
Why?
|
| Iris | 7 | 1982 | 232 | 0.150 |
Why?
|
| DNA, Ribosomal | 1 | 2019 | 300 | 0.150 |
Why?
|
| Ataxia | 1 | 2000 | 306 | 0.150 |
Why?
|
| DNA, Fungal | 1 | 2019 | 275 | 0.150 |
Why?
|
| Hyaluronic Acid | 2 | 2018 | 483 | 0.150 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 64 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1999 | 410 | 0.150 |
Why?
|
| Linkage Disequilibrium | 4 | 2017 | 1998 | 0.150 |
Why?
|
| Vestibular Diseases | 1 | 2000 | 230 | 0.150 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2002 | 487 | 0.150 |
Why?
|
| Sweat Gland Neoplasms | 2 | 2018 | 116 | 0.140 |
Why?
|
| Laurence-Moon Syndrome | 1 | 1997 | 9 | 0.140 |
Why?
|
| Osteosarcoma | 4 | 1989 | 897 | 0.140 |
Why?
|
| Prolactinoma | 1 | 2018 | 114 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 2 | 2004 | 1069 | 0.140 |
Why?
|
| Fatal Outcome | 4 | 2002 | 1834 | 0.140 |
Why?
|
| Genotype | 9 | 2008 | 12990 | 0.140 |
Why?
|
| Trabecular Meshwork | 1 | 2017 | 101 | 0.140 |
Why?
|
| Restriction Mapping | 6 | 1994 | 851 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 153 | 0.140 |
Why?
|
| Loss of Heterozygosity | 1 | 1999 | 662 | 0.140 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 4 | 1999 | 27 | 0.140 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1996 | 116 | 0.130 |
Why?
|
| Orbit | 1 | 2019 | 457 | 0.130 |
Why?
|
| Cosmetic Techniques | 1 | 2018 | 149 | 0.130 |
Why?
|
| Amyloid Neuropathies | 1 | 1995 | 15 | 0.130 |
Why?
|
| Membrane Glycoproteins | 4 | 1997 | 3702 | 0.130 |
Why?
|
| Protein Structure, Secondary | 2 | 1997 | 1229 | 0.130 |
Why?
|
| Fluorescein Angiography | 5 | 2014 | 1059 | 0.130 |
Why?
|
| Recombination, Genetic | 4 | 1999 | 1519 | 0.130 |
Why?
|
| Microsatellite Repeats | 4 | 2007 | 784 | 0.130 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 940 | 0.130 |
Why?
|
| Aged | 35 | 2021 | 169289 | 0.130 |
Why?
|
| Oculomotor Muscles | 1 | 2019 | 406 | 0.130 |
Why?
|
| Adolescent | 28 | 2015 | 88319 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2001 | 2665 | 0.120 |
Why?
|
| Cattle | 10 | 2017 | 3849 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2019 | 1062 | 0.120 |
Why?
|
| Valine | 2 | 2000 | 408 | 0.120 |
Why?
|
| Genetics, Medical | 1 | 1997 | 334 | 0.120 |
Why?
|
| Protein Kinase C | 1 | 1999 | 1202 | 0.120 |
Why?
|
| RNA, Messenger | 7 | 2021 | 12795 | 0.120 |
Why?
|
| Mosaicism | 1 | 1998 | 475 | 0.120 |
Why?
|
| Intraocular Pressure | 2 | 2018 | 1294 | 0.120 |
Why?
|
| Wet Macular Degeneration | 1 | 2016 | 162 | 0.120 |
Why?
|
| Transcription Factors | 3 | 2017 | 12128 | 0.120 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1479 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1991 | 1058 | 0.110 |
Why?
|
| Prealbumin | 1 | 1995 | 222 | 0.110 |
Why?
|
| Tears | 1 | 2015 | 251 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 6 | 2008 | 5789 | 0.110 |
Why?
|
| Testis | 1 | 2017 | 794 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 664 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 1379 | 0.110 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 3 | 1997 | 7 | 0.110 |
Why?
|
| Retinal Detachment | 3 | 2006 | 428 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 2872 | 0.110 |
Why?
|
| Genetic Markers | 6 | 1997 | 2601 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1961 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2004 | 150 | 0.110 |
Why?
|
| Amyloidosis | 1 | 2019 | 817 | 0.100 |
Why?
|
| Histidine | 2 | 2008 | 308 | 0.100 |
Why?
|
| Child | 23 | 2008 | 80153 | 0.100 |
Why?
|
| Serine | 1 | 1996 | 830 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1997 | 604 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 11076 | 0.100 |
Why?
|
| Ovary | 1 | 2017 | 959 | 0.100 |
Why?
|
| Drugs, Generic | 1 | 2018 | 448 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3810 | 0.100 |
Why?
|
| Perfusion | 1 | 2017 | 1373 | 0.100 |
Why?
|
| Chromosomes, Human, X | 2 | 2005 | 321 | 0.100 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 58976 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1993 | 201 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1999 | 1250 | 0.100 |
Why?
|
| Lipoproteins | 1 | 1997 | 881 | 0.100 |
Why?
|
| Smoking | 3 | 2007 | 9053 | 0.100 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2007 | 386 | 0.090 |
Why?
|
| Models, Animal | 1 | 2018 | 2112 | 0.090 |
Why?
|
| Darkness | 4 | 1995 | 158 | 0.090 |
Why?
|
| Binding Sites | 3 | 2017 | 6055 | 0.090 |
Why?
|
| Animals | 34 | 2023 | 168459 | 0.090 |
Why?
|
| Nevus, Pigmented | 2 | 2006 | 222 | 0.090 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2005 | 38 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1640 | 0.090 |
Why?
|
| Sp1 Transcription Factor | 1 | 1991 | 140 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2019 | 2116 | 0.090 |
Why?
|
| Complement Factor B | 2 | 2023 | 57 | 0.090 |
Why?
|
| Prescription Drugs | 1 | 2018 | 631 | 0.090 |
Why?
|
| Amyloid | 1 | 1995 | 841 | 0.090 |
Why?
|
| DNA, Neoplasm | 6 | 1991 | 1745 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2822 | 0.090 |
Why?
|
| Lacrimal Apparatus | 1 | 1992 | 223 | 0.090 |
Why?
|
| Phenotype | 9 | 2005 | 16591 | 0.090 |
Why?
|
| Mice | 21 | 2023 | 81525 | 0.090 |
Why?
|
| Collagen | 1 | 2018 | 2638 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1897 | 0.090 |
Why?
|
| Vitamin A | 2 | 2006 | 613 | 0.090 |
Why?
|
| Monophenol Monooxygenase | 3 | 1984 | 72 | 0.090 |
Why?
|
| Catechol Oxidase | 2 | 1980 | 2 | 0.080 |
Why?
|
| Usher Syndromes | 1 | 2010 | 56 | 0.080 |
Why?
|
| Hybrid Cells | 6 | 1996 | 422 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 18252 | 0.080 |
Why?
|
| Leucine | 1 | 1991 | 548 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 8002 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1324 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4575 | 0.080 |
Why?
|
| Blotting, Southern | 6 | 1997 | 777 | 0.080 |
Why?
|
| Methionine | 2 | 1991 | 572 | 0.080 |
Why?
|
| Antigens | 2 | 1995 | 1443 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2017 | 15936 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2005 | 2748 | 0.080 |
Why?
|
| Cell Line | 10 | 2006 | 15601 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3734 | 0.080 |
Why?
|
| Glaucoma | 2 | 2017 | 1185 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2005 | 1076 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 1943 | 0.080 |
Why?
|
| 3' Untranslated Regions | 2 | 2008 | 519 | 0.070 |
Why?
|
| Chromosomes, Human, 1-3 | 2 | 1986 | 21 | 0.070 |
Why?
|
| Retinoblastoma Protein | 5 | 1999 | 672 | 0.070 |
Why?
|
| Citric Acid Cycle | 1 | 2008 | 231 | 0.070 |
Why?
|
| Retinitis | 1 | 2007 | 36 | 0.070 |
Why?
|
| Lod Score | 4 | 1997 | 600 | 0.070 |
Why?
|
| DNA Probes | 3 | 1994 | 541 | 0.070 |
Why?
|
| Scleral Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Myofibroma | 1 | 2007 | 45 | 0.070 |
Why?
|
| Uveitis | 1 | 2010 | 395 | 0.070 |
Why?
|
| Choroid Neoplasms | 3 | 2003 | 177 | 0.070 |
Why?
|
| DNA Restriction Enzymes | 6 | 1986 | 550 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 1991 | 1768 | 0.070 |
Why?
|
| Light | 3 | 2004 | 1353 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2002 | 1991 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2180 | 0.070 |
Why?
|
| Blood Proteins | 1 | 1991 | 1173 | 0.070 |
Why?
|
| Hearing Loss | 2 | 2004 | 783 | 0.070 |
Why?
|
| Phosphenes | 1 | 2006 | 41 | 0.070 |
Why?
|
| Retrospective Studies | 9 | 2023 | 80636 | 0.060 |
Why?
|
| Tyrosine | 2 | 2008 | 1440 | 0.060 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2006 | 45 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3778 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2008 | 1985 | 0.060 |
Why?
|
| Conjunctival Diseases | 1 | 2006 | 110 | 0.060 |
Why?
|
| Intravitreal Injections | 2 | 2018 | 385 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1993 | 779 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1995 | 783 | 0.060 |
Why?
|
| Cornea | 2 | 2023 | 1333 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 3 | 1990 | 166 | 0.060 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2005 | 40 | 0.060 |
Why?
|
| Siblings | 2 | 2007 | 825 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2001 | 1342 | 0.060 |
Why?
|
| Pyridines | 1 | 2017 | 2875 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1985 | 1302 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 94 | 0.060 |
Why?
|
| Disease Progression | 3 | 2019 | 13506 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 5821 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2007 | 469 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2005 | 365 | 0.060 |
Why?
|
| NAD | 1 | 2008 | 614 | 0.060 |
Why?
|
| GTP-Binding Protein Regulators | 1 | 2004 | 12 | 0.060 |
Why?
|
| Microscopy, Electron | 4 | 1998 | 2561 | 0.060 |
Why?
|
| Granuloma | 1 | 2006 | 328 | 0.060 |
Why?
|
| Eye | 2 | 1979 | 712 | 0.060 |
Why?
|
| DNA, Satellite | 2 | 1994 | 66 | 0.060 |
Why?
|
| Transfection | 5 | 2002 | 5774 | 0.060 |
Why?
|
| Sound | 1 | 2006 | 257 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2015 | 12341 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1998 | 367 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2004 | 205 | 0.060 |
Why?
|
| Models, Structural | 2 | 1995 | 340 | 0.060 |
Why?
|
| Hyperopia | 1 | 2003 | 41 | 0.060 |
Why?
|
| Refractive Errors | 1 | 2005 | 147 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3492 | 0.050 |
Why?
|
| Osteoma | 1 | 2003 | 12 | 0.050 |
Why?
|
| Chromosome Banding | 4 | 1995 | 260 | 0.050 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2003 | 63 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 22169 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2005 | 253 | 0.050 |
Why?
|
| Hallucinations | 1 | 2006 | 366 | 0.050 |
Why?
|
| Rabbits | 3 | 2018 | 4772 | 0.050 |
Why?
|
| Temporal Arteries | 1 | 2004 | 154 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2003 | 815 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 412 | 0.050 |
Why?
|
| Dolphins | 1 | 2002 | 14 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1995 | 1434 | 0.050 |
Why?
|
| Glutamine | 2 | 2008 | 577 | 0.050 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 1022 | 0.050 |
Why?
|
| Visual Field Tests | 2 | 2006 | 411 | 0.050 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2023 | 144 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2418 | 0.050 |
Why?
|
| Glycine | 2 | 2008 | 663 | 0.050 |
Why?
|
| Gene Library | 2 | 2002 | 1059 | 0.050 |
Why?
|
| Vitamin E | 1 | 2006 | 872 | 0.050 |
Why?
|
| Eye Enucleation | 2 | 2006 | 128 | 0.050 |
Why?
|
| Genomic Library | 1 | 2002 | 189 | 0.050 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2008 | 938 | 0.050 |
Why?
|
| Psoriasis | 1 | 2010 | 950 | 0.050 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 931 | 0.050 |
Why?
|
| Leucine Zippers | 1 | 2002 | 116 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 891 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2898 | 0.050 |
Why?
|
| Uvea | 2 | 1978 | 30 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1986 | 592 | 0.050 |
Why?
|
| Optic Disk | 1 | 2006 | 421 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2004 | 705 | 0.050 |
Why?
|
| DNA, Single-Stranded | 2 | 1993 | 355 | 0.050 |
Why?
|
| Carcinoma | 2 | 1992 | 2330 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2004 | 3968 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2927 | 0.050 |
Why?
|
| Risk Factors | 7 | 2017 | 74206 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2006 | 521 | 0.050 |
Why?
|
| Vitamins | 2 | 2006 | 1635 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 1994 | 1749 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2018 | 9646 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2006 | 6567 | 0.040 |
Why?
|
| Autopsy | 2 | 2021 | 1008 | 0.040 |
Why?
|
| Vitrectomy | 3 | 2003 | 392 | 0.040 |
Why?
|
| Ophthalmoscopy | 2 | 2008 | 171 | 0.040 |
Why?
|
| Geographic Atrophy | 1 | 2021 | 91 | 0.040 |
Why?
|
| Uterine Hemorrhage | 1 | 2002 | 240 | 0.040 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 416 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 2003 | 951 | 0.040 |
Why?
|
| Karyotyping | 6 | 1990 | 1171 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2006 | 908 | 0.040 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2002 | 191 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 1998 | 9539 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29625 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1991 | 1545 | 0.040 |
Why?
|
| Oxygen | 2 | 2001 | 4227 | 0.040 |
Why?
|
| Injections, Intraocular | 1 | 2018 | 33 | 0.040 |
Why?
|
| Consanguinity | 2 | 2008 | 456 | 0.040 |
Why?
|
| Laminin | 1 | 2000 | 408 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3792 | 0.040 |
Why?
|
| Apocrine Glands | 1 | 2018 | 32 | 0.040 |
Why?
|
| Child, Preschool | 10 | 2007 | 42230 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 427 | 0.040 |
Why?
|
| Cysteinyldopa | 1 | 1977 | 1 | 0.040 |
Why?
|
| cis-trans-Isomerases | 1 | 1998 | 44 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10773 | 0.040 |
Why?
|
| Eccrine Glands | 1 | 2018 | 52 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1991 | 8547 | 0.040 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1977 | 74 | 0.040 |
Why?
|
| New England | 1 | 2001 | 1054 | 0.040 |
Why?
|
| Thymidine Kinase | 2 | 1990 | 286 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 1980 | 518 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2001 | 1152 | 0.040 |
Why?
|
| Chloride Channels | 1 | 1999 | 221 | 0.040 |
Why?
|
| Recoverin | 1 | 1997 | 11 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1999 | 452 | 0.040 |
Why?
|
| Hippocalcin | 1 | 1997 | 7 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 413 | 0.040 |
Why?
|
| Paternal Age | 1 | 1997 | 87 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 701 | 0.040 |
Why?
|
| Lacrimal Apparatus Diseases | 2 | 1992 | 72 | 0.040 |
Why?
|
| Tonometry, Ocular | 1 | 2018 | 235 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 1301 | 0.030 |
Why?
|
| Melanins | 1 | 1979 | 290 | 0.030 |
Why?
|
| Nuclear Family | 1 | 1998 | 311 | 0.030 |
Why?
|
| Medicare Part B | 1 | 2018 | 117 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 3826 | 0.030 |
Why?
|
| Leukocytes | 2 | 1998 | 2026 | 0.030 |
Why?
|
| Carcinoma, Adenoid Cystic | 3 | 1992 | 262 | 0.030 |
Why?
|
| Sensory Thresholds | 3 | 2008 | 377 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2003 | 1271 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1756 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20098 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2012 | 3429 | 0.030 |
Why?
|
| Complement C3 | 1 | 2018 | 435 | 0.030 |
Why?
|
| Half-Life | 1 | 2017 | 651 | 0.030 |
Why?
|
| Histones | 1 | 2006 | 2580 | 0.030 |
Why?
|
| Cataract | 1 | 2002 | 832 | 0.030 |
Why?
|
| Cell Survival | 1 | 2005 | 5791 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2017 | 302 | 0.030 |
Why?
|
| Hair | 1 | 1979 | 498 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 300 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2018 | 5035 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3763 | 0.030 |
Why?
|
| Chromosome Disorders | 2 | 1991 | 497 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 903 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 945 | 0.030 |
Why?
|
| Signal Transduction | 2 | 1995 | 23445 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 1693 | 0.030 |
Why?
|
| Fathers | 1 | 1997 | 376 | 0.030 |
Why?
|
| Menarche | 1 | 1977 | 532 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2001 | 2919 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1995 | 386 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 579 | 0.030 |
Why?
|
| Choroid Diseases | 1 | 1994 | 63 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 4 | 2008 | 2917 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2008 | 22176 | 0.030 |
Why?
|
| Mitosis | 1 | 1999 | 1187 | 0.030 |
Why?
|
| Retinal Dysplasia | 1 | 1993 | 12 | 0.030 |
Why?
|
| Axons | 1 | 2001 | 1674 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1994 | 310 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2004 | 5439 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1997 | 1232 | 0.030 |
Why?
|
| Poly A | 1 | 1993 | 181 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1984 | 455 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2018 | 741 | 0.030 |
Why?
|
| Cell Division | 1 | 2001 | 4465 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1994 | 373 | 0.030 |
Why?
|
| Iron | 1 | 2001 | 1793 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2006 | 5972 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1991 | 418 | 0.030 |
Why?
|
| Gene Amplification | 2 | 1989 | 1089 | 0.030 |
Why?
|
| United States | 4 | 2019 | 72334 | 0.030 |
Why?
|
| Young Adult | 3 | 2015 | 59243 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1996 | 1163 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9486 | 0.030 |
Why?
|
| Calcium | 2 | 2004 | 5722 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2001 | 4124 | 0.030 |
Why?
|
| Dog Diseases | 1 | 1993 | 141 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1494 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1994 | 255 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6766 | 0.020 |
Why?
|
| Reference Values | 1 | 1999 | 4920 | 0.020 |
Why?
|
| Activating Transcription Factors | 1 | 1991 | 30 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 1624 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1995 | 918 | 0.020 |
Why?
|
| Choroideremia | 1 | 1990 | 27 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 1996 | 1971 | 0.020 |
Why?
|
| Rats | 3 | 2002 | 23742 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2206 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 10209 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 902 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2024 | 0.020 |
Why?
|
| Adenovirus Early Proteins | 1 | 1989 | 57 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 3448 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1999 | 1405 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2010 | 41487 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1995 | 3597 | 0.020 |
Why?
|
| Equipment Design | 1 | 2017 | 3510 | 0.020 |
Why?
|
| Isocitrates | 1 | 2008 | 23 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 1994 | 1206 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1990 | 322 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1991 | 461 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 2510 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6484 | 0.020 |
Why?
|
| Hypopigmentation | 1 | 2008 | 43 | 0.020 |
Why?
|
| Lymphocytes | 3 | 2008 | 2612 | 0.020 |
Why?
|
| Methylation | 1 | 1991 | 1084 | 0.020 |
Why?
|
| Dogs | 1 | 1993 | 3839 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1989 | 257 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 1988 | 190 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5796 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 227 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1997 | 3442 | 0.020 |
Why?
|
| Age Factors | 2 | 2001 | 18395 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1989 | 340 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1993 | 944 | 0.020 |
Why?
|
| Swine | 1 | 2017 | 5915 | 0.020 |
Why?
|
| Infant | 8 | 2001 | 36192 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2897 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2047 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 1992 | 852 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 2009 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 482 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 3085 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 1991 | 1125 | 0.020 |
Why?
|
| Plasmids | 2 | 1989 | 2269 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1667 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 2006 | 2161 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 39967 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6534 | 0.020 |
Why?
|
| Germ Cells | 1 | 1989 | 634 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 1988 | 427 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 1989 | 1787 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1699 | 0.020 |
Why?
|
| Guanylate Cyclase-Activating Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9420 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 934 | 0.020 |
Why?
|
| Androstadienes | 1 | 2006 | 348 | 0.010 |
Why?
|
| Computational Biology | 2 | 2010 | 3518 | 0.010 |
Why?
|
| Middle East | 1 | 2005 | 231 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2006 | 704 | 0.010 |
Why?
|
| Cricetinae | 2 | 1991 | 2423 | 0.010 |
Why?
|
| Eye Color | 1 | 2004 | 36 | 0.010 |
Why?
|
| Albinism | 1 | 1984 | 25 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1994 | 3395 | 0.010 |
Why?
|
| Ultraviolet Rays | 3 | 1990 | 1080 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1990 | 3416 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1995 | 8320 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2001 | 5440 | 0.010 |
Why?
|
| Species Specificity | 2 | 2002 | 2414 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 284 | 0.010 |
Why?
|
| Necrosis | 2 | 2003 | 1611 | 0.010 |
Why?
|
| Demography | 1 | 2008 | 1648 | 0.010 |
Why?
|
| Vision Tests | 1 | 1984 | 161 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1997 | 4398 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 569 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 9351 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2003 | 131 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 685 | 0.010 |
Why?
|
| Sweden | 1 | 2005 | 1379 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7967 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1741 | 0.010 |
Why?
|
| Fovea Centralis | 1 | 2003 | 126 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1991 | 3688 | 0.010 |
Why?
|
| Autoradiography | 1 | 1983 | 728 | 0.010 |
Why?
|
| Genome, Human | 1 | 1994 | 4425 | 0.010 |
Why?
|
| Occupational Diseases | 2 | 1980 | 1490 | 0.010 |
Why?
|
| Trisomy | 1 | 1983 | 260 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 1996 | 26198 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2006 | 1235 | 0.010 |
Why?
|
| Rodentia | 1 | 1983 | 262 | 0.010 |
Why?
|
| Medicare | 1 | 2019 | 6770 | 0.010 |
Why?
|
| Japan | 1 | 2005 | 1378 | 0.010 |
Why?
|
| Horner Syndrome | 1 | 1980 | 36 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1982 | 218 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 368 | 0.010 |
Why?
|
| Epithelium, Corneal | 1 | 2003 | 253 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1991 | 7594 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2571 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1989 | 2909 | 0.010 |
Why?
|
| Pigmentation | 1 | 1980 | 144 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 39106 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2001 | 615 | 0.010 |
Why?
|
| Keratitis | 1 | 2003 | 241 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 2004 | 306 | 0.010 |
Why?
|
| HIV Infections | 1 | 2006 | 17351 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1982 | 491 | 0.010 |
Why?
|
| Chemical Industry | 1 | 1980 | 116 | 0.010 |
Why?
|
| Conjunctiva | 1 | 2003 | 479 | 0.010 |
Why?
|
| Prednisone | 1 | 2004 | 1563 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20570 | 0.010 |
Why?
|
| Forecasting | 1 | 1988 | 2928 | 0.010 |
Why?
|
| Ophthalmia, Sympathetic | 1 | 1979 | 18 | 0.010 |
Why?
|
| Neuroglia | 1 | 1985 | 956 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 36426 | 0.010 |
Why?
|
| China | 1 | 2005 | 2369 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6343 | 0.010 |
Why?
|
| Epithelium | 1 | 2003 | 1603 | 0.010 |
Why?
|
| Electrooculography | 1 | 1998 | 113 | 0.010 |
Why?
|
| Sulfur | 1 | 1979 | 162 | 0.010 |
Why?
|
| Device Removal | 1 | 2003 | 630 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 9031 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 1897 | 0.010 |
Why?
|
| Color | 1 | 1979 | 299 | 0.010 |
Why?
|
| Diterpenes | 1 | 1998 | 171 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23995 | 0.010 |
Why?
|
| Corneal Diseases | 1 | 2003 | 542 | 0.010 |
Why?
|
| X-Rays | 2 | 1990 | 307 | 0.010 |
Why?
|
| France | 1 | 1998 | 497 | 0.010 |
Why?
|
| Models, Biological | 1 | 1993 | 9469 | 0.010 |
Why?
|
| Eye Injuries | 1 | 1980 | 227 | 0.010 |
Why?
|
| Educational Status | 1 | 2004 | 2522 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2003 | 2115 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 646 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1994 | 6132 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1994 | 89 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10090 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 1784 | 0.010 |
Why?
|
| Lac Operon | 1 | 1994 | 237 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1994 | 698 | 0.010 |
Why?
|
| Reoperation | 1 | 2003 | 4303 | 0.010 |
Why?
|
| Methotrexate | 1 | 1999 | 1719 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 2244 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 2688 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 4028 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 1998 | 18965 | 0.010 |
Why?
|
| Dopamine | 1 | 1977 | 1607 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10552 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1994 | 1529 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 3076 | 0.010 |
Why?
|
| Family | 1 | 2000 | 3194 | 0.010 |
Why?
|
| Cricetulus | 1 | 1991 | 814 | 0.010 |
Why?
|
| Mutagens | 1 | 1990 | 179 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 64680 | 0.010 |
Why?
|
| Genes | 1 | 1991 | 1823 | 0.000 |
Why?
|
| Organelles | 1 | 1989 | 266 | 0.000 |
Why?
|
| Mitomycins | 1 | 1986 | 46 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1659 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14666 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2004 | 12953 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1989 | 2016 | 0.000 |
Why?
|
| Mitomycin | 1 | 1986 | 263 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1994 | 6216 | 0.000 |
Why?
|
| Epidemiologic Methods | 2 | 1980 | 1336 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1989 | 1510 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1984 | 310 | 0.000 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1985 | 553 | 0.000 |
Why?
|
| Nystagmus, Pathologic | 1 | 1984 | 105 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1989 | 3615 | 0.000 |
Why?
|
| Esotropia | 1 | 1984 | 99 | 0.000 |
Why?
|
| Liver | 1 | 1998 | 7529 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2113 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1977 | 4486 | 0.000 |
Why?
|
| Adenoma, Sweat Gland | 1 | 1982 | 17 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1985 | 1705 | 0.000 |
Why?
|
| Cystadenoma | 1 | 1982 | 79 | 0.000 |
Why?
|
| Calcinosis | 1 | 1989 | 1469 | 0.000 |
Why?
|
| West Virginia | 1 | 1980 | 31 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1984 | 1085 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 12148 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1989 | 2825 | 0.000 |
Why?
|
| Microspheres | 1 | 1982 | 784 | 0.000 |
Why?
|
| Translocation, Genetic | 1 | 1984 | 1393 | 0.000 |
Why?
|
| Brain | 1 | 2006 | 27112 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 15500 | 0.000 |
Why?
|
| Nevus | 1 | 1980 | 205 | 0.000 |
Why?
|
| Astrocytes | 1 | 1985 | 1346 | 0.000 |
Why?
|
| Incidence | 1 | 1995 | 21353 | 0.000 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 1980 | 354 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1983 | 2257 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1984 | 5869 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1986 | 4758 | 0.000 |
Why?
|
| Adenoma | 1 | 1982 | 2160 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1980 | 4915 | 0.000 |
Why?
|